FDA on Friday published a list of molecular tests for COVID-19 that may be affected by mutations in the omicron variant of concern that continues to spread across the globe.
The agency's list focuses on coronavirus tests impacted by S-gene drop out, an occurrence that is most commonly associated with Thermo Fisher Scientific's TaqPath test kits. When TaqPath is used on a variant with a deletion in the spike gene, such as alph
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,